Another study found that the differentiation therapy consisting of four compounds, dexamethasone, isobutylmethylxanthine (IBMX), indomethacin, and insulin, could induce adipogenic differentiation of DDLPS cells and inhibit tumor growth both ex vivo and in vivo [24]. This evidence concerns the gene INS and neoplasm.